{
    "clinical_study": {
        "@rank": "61917", 
        "acronym": "STOP-AUST", 
        "arm_group": [
            {
                "arm_group_label": "Tranexamic Acid", 
                "arm_group_type": "Active Comparator", 
                "description": "Intravenous tranexamic acid 1000 mg in 100 mL 0.9% NaCl over 10 minutes followed by 1000 mg in 500 mL 0.9% NaCl infusion over 8 hours."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Intravenous placebo in 100 mL 0.9% NaCl over 10 minutes followed by 500 mL 0.9% NaCl infusion over 8 hours."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to test if intracerebral haemorrhage (ICH) patients who have\n      contrast extravasation on computed tomography angiography, the \"spot sign\", have lower rates\n      of haematoma growth when treated with tranexamic acid within 4.5 hours of stroke onset,\n      compared to placebo."
        }, 
        "brief_title": "STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Intracerebral Haemorrhage", 
            "Stroke"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Stroke", 
                "Cerebral Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients presenting with an acute ICH\n\n          -  Contrast extravasation within the haemorrhage, \"spot sign\", evaluated from the CTA\n             according to three criteria, all of which must be present:\n\n               1. Serpiginous or spot-like appearance within the margin of a parenchymal haematoma\n                  without connection to an outside vessel;\n\n               2. The density (in Hounsfield units) should be greater than that of the background\n                  haematoma (site investigators are not required to document the density); and\n\n               3. No hyperdensity at the corresponding location on non-contrast CT.\n\n          -  Age \u226518 years\n\n          -  Treatment can commence within 1 hour of initial CT and within 4.5 hours of symptom\n             onset (or in patients with unknown time of symptom onset, the time patient was last\n             known to be well)\n\n          -  Informed consent has been received in accordance to local ethics committee\n             requirements\n\n        Exclusion Criteria:\n\n          -  Glasgow coma scale (GCS) total score of <8\n\n          -  Brainstem ICH\n\n          -  ICH volume >70 ml as measured by the ABC/2 method\n\n          -  ICH known or suspected by study investigator to be secondary to trauma, aneurysm,\n             vascular malformation, haemorrhagic transformation of ischaemic stroke, cerebral\n             venous thrombosis, thrombolytic therapy, tumor, or infection\n\n          -  Contrast already administered within 24 hours prior to initial CT or contraindication\n             to imaging with CT contrast agents (e.g. known or suspected iodine allergy or\n             significant renal failure)\n\n          -  Any history or current evidence suggestive of venous or arterial thrombotic events\n             within the previous 12 months, including clinical, ECG, laboratory, or imaging\n             findings. Clinically silent chance findings of old ischemia are not considered\n             exclusion.\n\n          -  Pre-stroke modified Rankin Scale (mRS) score of >2\n\n          -  Hereditary or acquired haemorrhagic diathesis or coagulation factor deficiency.\n\n          -  Use of heparin, low-molecular weight heparin, GPIIb/IIIa antagonist, or oral\n             anticoagulation (e.g. warfarin, factor Xa inhibitor, thrombin inhibitor) within the\n             previous 14 days, irrespective of laboratory values\n\n          -  Pregnancy (women of childbearing potential must be tested)\n\n          -  Planned surgery for ICH within 24 hours\n\n          -  Concurrent or planned treatment with haemostatic agents (e.g. prothrombin complex\n             concentrate, vitamin K, fresh frozen plasma, or platelet transfusion)\n\n          -  Participation in any investigational study in the last 30 days\n\n          -  Known terminal illness or planned withdrawal of care or comfort care measures.\n\n          -  Any condition that, in the judgment of the investigator could impose hazards to the\n             patient if study therapy is initiated or affect the participation of the patient in\n             the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01702636", 
            "org_study_id": "NTA1201"
        }, 
        "intervention": [
            {
                "arm_group_label": "Tranexamic Acid", 
                "intervention_name": "Tranexamic Acid", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antifibrinolytic Agents", 
                "Tranexamic Acid", 
                "Cardiovascular Agents", 
                "Fibrin Modulating Agents"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Intracerebral Hemorrhage", 
            "ICH", 
            "Stroke", 
            "Cerebrovascular Disorders", 
            "Brain Diseases", 
            "Central Nervous System Diseases", 
            "Nervous System Diseases", 
            "Vascular Diseases", 
            "Cardiovascular Diseases", 
            "Tranexamic Acid", 
            "Antifibrinolytic Agents", 
            "Fibrin Modulating Agents", 
            "Pharmacologic Actions", 
            "Cardiovascular Agents", 
            "Therapeutic Uses", 
            "Hematologic Agents", 
            "Hemostatics", 
            "Contrast Media", 
            "Angiography", 
            "Cerebral Angiography", 
            "Tomography, X-Ray Computed"
        ], 
        "lastchanged_date": "March 19, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Kanwal", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2259"
                    }, 
                    "name": "Gosford Hospital"
                }, 
                "investigator": {
                    "last_name": "Jonathan Sturm, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2310"
                    }, 
                    "name": "John Hunter Hospital"
                }, 
                "investigator": {
                    "last_name": "Neil Spratt", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sydney", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2010"
                    }, 
                    "name": "St. Vincent's Hospital"
                }, 
                "investigator": {
                    "last_name": "Romesh Markus", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sydney", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2050"
                    }, 
                    "name": "Royal Prince Alfred Hospital"
                }, 
                "investigator": {
                    "last_name": "Candice Delcourt", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Westmead", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2145"
                    }, 
                    "name": "Westmead Hospital"
                }, 
                "investigator": {
                    "last_name": "Neil Mahant", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Adelaide", 
                        "country": "Australia", 
                        "state": "South Australia", 
                        "zip": "5011"
                    }, 
                    "name": "Queen Elizabeth Hospital"
                }, 
                "investigator": {
                    "last_name": "Jim Jannes", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Adelaide", 
                        "country": "Australia", 
                        "state": "South Australia", 
                        "zip": "5000"
                    }, 
                    "name": "Royal Adelaide Hospital"
                }, 
                "investigator": {
                    "last_name": "Timothy Kleinig", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Adelaide", 
                        "country": "Australia", 
                        "state": "South Australia", 
                        "zip": "5112"
                    }, 
                    "name": "Lyell McEwin Hospital"
                }, 
                "investigator": {
                    "last_name": "Timothy Kleinig", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bedford Park", 
                        "country": "Australia", 
                        "state": "South Australia", 
                        "zip": "5042"
                    }, 
                    "name": "Flinders Medical Centre"
                }, 
                "investigator": {
                    "last_name": "Andrew Lee", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Box Hill", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3128"
                    }, 
                    "name": "Box Hill Hospital"
                }, 
                "investigator": {
                    "last_name": "Christopher Bladin", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Epping", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3076"
                    }, 
                    "name": "Northern Hospital"
                }, 
                "investigator": {
                    "last_name": "Jorge Zavala", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Footscray", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3011"
                    }, 
                    "name": "Western Hospital"
                }, 
                "investigator": {
                    "last_name": "Tissa Wijeratne", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankston", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3199"
                    }, 
                    "name": "Frankston Hospital"
                }, 
                "investigator": {
                    "last_name": "Jayantha Rupasinghe", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Melbourne", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3004"
                    }, 
                    "name": "Alfred Hospital"
                }, 
                "investigator": {
                    "last_name": "Jorge Zavala", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Melbourne", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3050"
                    }, 
                    "name": "The Royal Melbourne Hospital"
                }, 
                "investigator": {
                    "last_name": "Stephen M Davis", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Australia"
        }, 
        "number_of_arms": "2", 
        "official_title": "STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial.", 
        "other_outcome": [
            {
                "description": "Exploratory analyses will be run with adjustments for baseline variables such as age, Glasgow Coma Scale (GCS), presence of IVH, and ICH location, and in the following subgroups: onset-to-treatment time (<3 vs. >3 hours); baseline ICH volume (<30 vs. >30 ml); anatomical location (deep, lobar, or cerebellar); IVH (absent vs. present); GCS (>12 vs. 8-12) and age (<70 vs. >70). These analyses will be hypothesis generating, as the trial is not powered for them.", 
                "measure": "ICH growth", 
                "safety_issue": "No", 
                "time_frame": "24+/-3 hours"
            }, 
            {
                "description": "Exploratory analyses will be run with adjustments for baseline variables such as age, Glasgow Coma Scale (GCS), presence of IVH, and ICH location, and in the following subgroups: onset-to-treatment time (<3 vs. >3 hours); baseline ICH volume (<30 vs. >30 ml); anatomical location (deep, lobar, or cerebellar); IVH (absent vs. present); GCS (>12 vs. 8-12) and age (<70 vs. >70). These analyses will be hypothesis generating, as the trial is not powered for them.", 
                "measure": "modified Rankin Scale (mRS)", 
                "safety_issue": "No", 
                "time_frame": "90+/-7 days"
            }
        ], 
        "overall_contact": {
            "email": "atte.meretoja@unimelb.edu.au", 
            "last_name": "Atte Meretoja, MD", 
            "phone": "+61 3 9342 8443"
        }, 
        "overall_official": [
            {
                "affiliation": "Melbourne Health", 
                "last_name": "Stephen M Davis, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The Florey Institute of Neuroscience and Mental Health", 
                "last_name": "Geoffrey A Donnan, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Australia: Department of Health and Ageing Therapeutic Goods Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "ICH growth by 24\u00b13 hours as defined by either 33% or 6 ml increase from baseline, adjusted for baseline ICH volume.", 
            "safety_issue": "No", 
            "time_frame": "24+/-3 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01702636"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Major thromboembolic events (myocardial infarction, ischaemic stroke, pulmonary embolism)", 
                "safety_issue": "Yes", 
                "time_frame": "Within 90+/-7 days"
            }, 
            {
                "measure": "Absolute ICH growth volume by 24\u00b13 hours, adjusted for baseline ICH volume", 
                "safety_issue": "No", 
                "time_frame": "24+/-3 hours"
            }, 
            {
                "measure": "Absolute intraventricular haematoma (IVH) growth volume by 24\u00b13 hours, adjusted for baseline IVH volume", 
                "safety_issue": "No", 
                "time_frame": "24+/-3 hours"
            }, 
            {
                "measure": "modified Rankin Scale (mRS) score of 0-4 at 3 months", 
                "safety_issue": "No", 
                "time_frame": "90+/-7 days"
            }, 
            {
                "measure": "modified Rankin Scale (mRS) score of 0-3 at 3 months", 
                "safety_issue": "No", 
                "time_frame": "90+/-7 days"
            }, 
            {
                "measure": "Categorical shift in mRS at 3 months, subject to the validity of proportional odds assumption", 
                "safety_issue": "No", 
                "time_frame": "90+/-7 days"
            }, 
            {
                "measure": "Death due to any cause by 3 months", 
                "safety_issue": "No", 
                "time_frame": "within 90+/-7 days"
            }
        ], 
        "source": "National Stroke Research Institute, Australia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Stroke Research Institute, Australia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}